Subscribe
shutterstock-253280038-web
Hamara / Shutterstock.com
4 March 2015Americas

Federal Circuit wipes $100m damages award in Medtronic case

The US Court of Appeals for the Federal Circuit has overturned a $100 million damages sum awarded to Medtronic Sofamor Danek (MSD) in a long-fought patent case between the medical device maker and San Diego-based NuVasive.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages